7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Pregnancy Complications, Hematologic D011250 11 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Venous Thrombosis D020246 11 associated lipids
Thinness D013851 11 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Crohn Disease D003424 12 associated lipids
Familial Mediterranean Fever D010505 12 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Osteoporosis D010024 12 associated lipids
Hypocalcemia D006996 12 associated lipids
Disease Susceptibility D004198 12 associated lipids
Hypercalcemia D006934 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Multiple Myeloma D009101 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Polycythemia Vera D011087 13 associated lipids
Stomatitis D013280 14 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Angina, Unstable D000789 14 associated lipids
Synovitis D013585 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Periodontal Diseases D010510 15 associated lipids
Encephalitis D004660 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Celiac Disease D002446 16 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Brain Infarction D020520 17 associated lipids
Carcinoma D002277 18 associated lipids
Albuminuria D000419 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
HIV Infections D015658 20 associated lipids
Wounds and Injuries D014947 20 associated lipids
Cachexia D002100 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Periodontitis D010518 22 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Obesity D009765 29 associated lipids
Endometriosis D004715 29 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Cao H et al. Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery. 2014 Cardiology pmid:24434592
Lenglet S et al. Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. 2014 Mediators Inflamm. pmid:24648660
Takeshita S et al. Age-related marrow adipogenesis is linked to increased expression of RANKL. 2014 J. Biol. Chem. pmid:24753250
Yamamoto N et al. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Int. J. Mol. Med. pmid:25234201
Olivares-Navarrete R et al. Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. 2014 Ann Biomed Eng pmid:25227453
Giuliani AL et al. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. 2014 PLoS ONE pmid:25226385
Li B et al. Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. 2014 Stem Cells Dev. pmid:24827498
Lee SI et al. NOD2 Mediates Odontoblast Differentiation and RANKL Expression. 2014 J. Dent. Res. pmid:24820666
Marques EA et al. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. 2013 Sep-Oct Arch Gerontol Geriatr pmid:23623588
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Canto-Cetina T et al. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. 2013 Nov-Dec Am. J. Hum. Biol. pmid:24130145
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Zamora PO et al. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. 2013 Mar-Apr Int. J. Toxicol. pmid:23422080
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Nanjundaiah SM et al. Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. 2013 Jan-Mar Int J Immunopathol Pharmacol pmid:23527707
Wang ST et al. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. 2013 Clin. Nephrol. pmid:23073066
Honma M et al. RANKL subcellular trafficking and regulatory mechanisms in osteocytes. 2013 J. Bone Miner. Res. pmid:23529793
Vinholt PJ et al. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. 2013 Thromb. Res. pmid:23531238
Shang M et al. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. 2013 Clin. Biochem. pmid:23531404
Jin J et al. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. 2013 J. Surg. Res. pmid:22487394
Zhan X et al. Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. 2013 Dent Traumatol pmid:22487464
Kadow-Romacker A et al. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro. 2013 J Biomater Appl pmid:21862509
Hakimi M et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. 2013 Int. J. Mol. Med. pmid:23722820
Marshall AJ et al. Long-chain triazolyl acids as inhibitors of osteoclastogenesis. 2013 Bioorg. Med. Chem. pmid:23726411
Brzóska MM and Rogalska J Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. 2013 Toxicol. Appl. Pharmacol. pmid:23726800
Van Schepdael A et al. A mechanobiological model of orthodontic tooth movement. 2013 Biomech Model Mechanobiol pmid:22539046
Kim J et al. Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. 2013 Clin. Biochem. pmid:23726804
Saini V et al. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. 2013 J. Biol. Chem. pmid:23729679
Wan S Editorial comment: The end of all our exploring ... 2013 Eur J Cardiothorac Surg pmid:23729753
Recht M et al. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. 2013 Haemophilia pmid:23731369
Czyzewska-Buczyńska A et al. [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients]. 2013 Prz. Lek. pmid:24003660
Fathilah SN et al. Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model. 2013 BMC Complement Altern Med pmid:24007208
Einvik G et al. Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. 2013 J Affect Disord pmid:22862888
Koufany M et al. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. 2013 Arthritis Rheum. pmid:23982996
Mozzati M et al. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. 2013 Clin Oral Investig pmid:22864527
Ma XN et al. [Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts]. 2013 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:23987492
Naumnik B et al. Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. 2013 Adv Med Sci pmid:23959668
Belibasakis GN et al. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease. 2013 Int Endod J pmid:22900632
Kim SD et al. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. 2013 Biochem. Pharmacol. pmid:23928189
Crosley LK et al. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. 2013 Mol Nutr Food Res pmid:23934705
Tarantino U et al. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab. 2013 Aging Clin Exp Res pmid:24046047
Nahidi L et al. Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. 2013 Dig. Dis. Sci. pmid:24048682
Hope S et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. 2013 Schizophr. Res. pmid:23403415
Thormann U et al. Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. 2013 Biomaterials pmid:23906515
D'Amico L et al. Bone metastases in gastric cancer follow a RANKL-independent mechanism. 2013 Oncol. Rep. pmid:23404437
Lekesiz K et al. Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. 2013 Folia Histochem. Cytobiol. pmid:23907946
Briana DD et al. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23406471
Enhos S et al. OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23910201
McDonald MM et al. Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity. 2013 J. Bone Miner. Res. pmid:23408642
Callegari A et al. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23990207
Oshita K et al. [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. 2013 J. UOEH pmid:23475022
Kress DC Invited commentary. 2013 Ann. Thorac. Surg. pmid:23992687
Mozzanega B et al. Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. 2013 J. Bone Miner. Metab. pmid:23479185
de Matos FR et al. Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors. 2013 J. Oral Maxillofac. Surg. pmid:23992784
Calderín S et al. Short-term clinical and osteoimmunological effects of scaling and root planing complemented by simple or repeated laser phototherapy in chronic periodontitis. 2013 Lasers Med Sci pmid:22546942
Yano S et al. Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. 2013 Zool. Sci. pmid:23480382
Ghaffari S et al. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. 2013 Cardiol J pmid:23788300
Shen L et al. Association between osteoprotegerin genetic variants and bone mineral density in Chinese women. 2013 Int. Immunopharmacol. pmid:23619553
Xie GQ et al. Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women. 2013 Clin. Chim. Acta pmid:23643930
Aranha AM et al. Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. 2013 J Endod pmid:23228262
Ding CZ et al. [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23646485
Wang XF et al. The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. 2013 Mol Med Rep pmid:23440406
Jiang S et al. Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. 2013 Poult. Sci. pmid:23687138
Srivastava S et al. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. 2013 Phytomedicine pmid:23570998
Fu YX et al. Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. 2013 Poult. Sci. pmid:23687158
Lou Z et al. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. 2013 Med. Oncol. pmid:23690270
Suliburska J et al. The association of insulin resistance with serum osteoprotegerin in obese adolescents. 2013 J. Physiol. Biochem. pmid:23695991
Kim J et al. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. 2013 J. Bone Miner. Res. pmid:23633269
Tetè S et al. Maxillary sinus augmentation procedures through equine-derived biomaterial or calvaria autologous bone: immunohistochemical evaluation of OPG/RANKL in humans. 2013 Eur J Histochem pmid:23549459
Kuang B et al. Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. 2013 Am J Orthod Dentofacial Orthop pmid:23273362
Matsuzaki E et al. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. 2013 Bone pmid:23612487
Flórez-Moreno GA et al. Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23273364
Brown TT et al. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. 2013 J. Acquir. Immune Defic. Syndr. pmid:23591634
Hyseni A et al. Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. 2013 Thromb. Res. pmid:23273402
Feng X et al. Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. 2013 Clin. Dev. Immunol. pmid:24348674
Engvall IL et al. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. 2013 Rheumatology (Oxford) pmid:23275387
Levidou G et al. TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. 2013 Pathology pmid:23277172
de Moraes M et al. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. 2013 J. Oral Pathol. Med. pmid:23278112
Peris P et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. 2013 Mayo Clin. Proc. pmid:23228561
Zhang W et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. 2013 Inflammation pmid:22945280
Dieckmann M et al. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. 2013 J. Bone Miner. Res. pmid:22991192
Ambroszkiewicz J et al. Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis. 2013 Adv Med Sci pmid:24277958
Wong KC et al. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. 2013 Br. J. Nutr. pmid:23302510
Wada T [RANKL inhibition in bone metastases]. 2013 Nippon Yakurigaku Zasshi pmid:23302944
Shao B et al. [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. 2013 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24321069
Jiang H et al. A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. 2013 BMC Pregnancy Childbirth pmid:24321402
Naranjo-Suarez S et al. Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. 2013 Mol. Cells pmid:23912593
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Zhang J et al. Occlusal effects on longitudinal bone alterations of the temporomandibular joint. 2013 J. Dent. Res. pmid:23340211
Yang B et al. Effect of radiation on the Notch signaling pathway in osteoblasts. 2013 Int. J. Mol. Med. pmid:23340672
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Dalcico R et al. Protective mechanisms of simvastatin in experimental periodontal disease. 2013 J. Periodontol. pmid:23181416
Balani D et al. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. 2013 Arthritis Rheum. pmid:23124514
Osorio A et al. Biochemical markers of vascular calcification in elderly hemodialysis patients. 2013 Mol. Cell. Biochem. pmid:23124853
Kim HS et al. The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells. 2013 Int. J. Mol. Med. pmid:23128413
Mogelvang R et al. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. 2013 Heart pmid:23135978
Ciccone MM et al. Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases. 2013 J Cardiovasc Med (Hagerstown) pmid:22772598
Wolf M et al. Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. 2013 Clin Oral Investig pmid:22777389

Table of Content